Opportunity

TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform

Response due

December 3, 2026

Buyer: Triad - Doe Contractor
Agency: Triad - Doe Contractor
Estimated value: Not stated

Key dates

Posted: June 4, 2026
Response due: December 3, 2026

Who is this buyer

Triad - Doe Contractor

Organization

Triad - Doe Contractor

Buying history

Records3 total
Opportunities / awards1 / 0
ActiveMay 11, 2026 – August 14, 2026

What they buy

Clinical (3)

Set-asides used

No Set aside used (3)

View source document →

Source link on sam.gov.

Source record

Buyer type: Federal
Jurisdiction: Federal (US)
Category: Clinical
Set-aside: No Set aside used
NAICS: 325412
PSC: 6505